Phase 2 ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a teenager between 12 and 17 years old
- You have been diagnosed with ADHD, confirmed using a specific standard questionnaire called the SNAP-IV
- You have previously tried treatments for ADHD (either medication or other types of therapy) but did not see significant improvement in your symptoms
- You do not have any serious mental health conditions or major physical health problems alongside your ADHD
- Both you and your parent or legal guardian are able to understand what the study involves
- Your parent or legal guardian is willing to sign a consent form, and you are willing to agree to take part
Who may not be able to join:
- You have used any cannabis-based products (natural or synthetic) in the 30 days before the study starts
- You have a history of bad reactions to cannabis-based products, such as confusion, paranoia, severe drowsiness, itching, vomiting, diarrhea, or seizures
- You have a significant physical health condition (confirm with trial site)
- You have a serious mental health disorder that is not related to ADHD
- You have moderate to severe difficulties with thinking, learning, or memory
- You are unwilling or unable to complete the study activities or fill in the required questionnaires
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +55 48 9 8833-6460
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Attention-Deficit/Hyperactivity Disorder symptom severity assessed by the Swanson, Nolan and Pelham Questionnaire, version IV
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.